Category:

Eco/Invest/Demography

Experts question U.S. Government’s mechanism to handle COVID-19 vaccine injury claims

Unlike the more established federal vaccine court, which decides cases of injury from most childhood vaccines and other common inoculations, the Countermeasures Injury Compensation Program was created by a 2005 law specifically to deal with vaccines developed under emergency authorization. The idea was to allow pharmaceutical companies and government entities the freedom to develop and distribute vaccines to meet urgent public health needs without the threat of being overrun with expensive liability lawsuits. Under the program, drug makers can only be sued for “willful misconduct.”

read more

UK insurer sells price comparison unit to Zoopla in $685 million deal

Under the deal, a unit of ZPG Ltd. will acquire Admiral’s Penguin Portals Group, which operates online platforms that help consumers compare the cost of services such as insurance products, mortgages, energy supplies and Internet connections. ZPG, which was bought by U.S. private-equity firm Silver Lake in 2018, will add brands including Confused.com and Rastreator.com to its existing platforms including Zoopla and Uswitch.

read more

UK rolls out Astra/Oxford COVID vaccine after world-first approval

Crucially for countries with relatively basic health infrastructure, the AstraZeneca/Oxford vaccine can be stored and transported under normal refrigeration, rather than supercooled to -70 degrees Celsius (-94 Fahrenheit).

India is keen to start administering the new shot next month; Serum Institute of India (SII), the world’s biggest producer of vaccines, has already made about 50 million doses. Chile is also interested.

read more

Suspension of scheduled international passenger flights extended till Jan 31

Scheduled international passenger services have been suspended in India since March 23 due to the coronavirus pandemic. But special international flights have been operating under the Vande Bharat Mission since May and under bilateral “air bubble” arrangements with selected countries since July.
India has formed air bubble pacts with 24 countries including the US, the UK, the UAE, Kenya, Bhutan and France. Under an air bubble pact between two countries, special international flights can be operated by their airlines between their territories.

read more

California nurse tests Covid positive week after receiving Pfizer vaccine

Christian Ramers, an infectious disease specialist with Family Health Centers of San Diego, told the ABC News affiliate that this scenario was not unexpected.

“We know from the vaccine clinical trials that it’s going to take about 10 to 14 days for you to start to develop protection from the vaccine,” Ramers said.

“That first dose we think gives you somewhere around 50%, and you need that second dose to get up to 95%,” Ramers added.

read more

Labour codes to herald new wave of reforms in 2021; job creation likely to be major challenge

during the pandemic, the central government was successful in getting Parliament’s approval for three labour codes on Industrial Relations, Social Security and Occupational Health Safety & Working Conditions (OSH) this year

The Code on Wages was approved by Parliament last year and its rules have been firmed up. But the implementation of the rules for Code on Wages was held back because the government wanted to implement all four labour codes in one go

read more

Assessing 2020:Fight against COVID-19 kept health ministry on its toes

At present, six COVID-19 vaccines are undergoing clinical trials in India.

They are: Covaxin, developed by Bharat Biotech in collaboration with ICMR; Oxford vaccine manufactured by SII under licence from AstraZeneca; ZyCOV-D being developed by Cadila Healthcare Ltd in Ahmedabad in collaboration with the Centre”s Department of Biotechnology; Sputnik V vaccine manufactured by Dr Reddy”s Lab, Hyderabad, in collaboration with Russia”s Gamaleya National Centre; one manufactured by Biological E Ltd, Hyderabad, in collaboration with MIT, US and the sixth developed by Pune-based Gennova Biopharmaceuticals Ltd in collaboration with HDT, US.

Besides, there is NVX-CoV2373, which is being developed by SII in collaboration with Novavax and its phase-3 clinical trial is under consideration with the drug regulator.

read more

Andhra CM credits YSR Rythu Bharosa, Nivar cyclone compensation into farmers’ bank accounts

Under ‘Rytu Bharosa – PM Kisan’ scheme, the Andhra Pradesh Chief Minister has released Rs 1,120 crores as third instalment to 51.59 lakh farmers. The first instalment was released on May 15, 2020 ahead of Khariff season under which Rs 3,713 crores were credited to 49.45 lakh farmer families, while the second instalment of Rs 2,095 crores was released on October 27, 2020 for 50.47 lakh farmer families.

read more